Alicia completed a PhD in Biochemistry and Molecular Biology at Melbourne University in 2003 and subsequently worked as a post-doctoral fellow for many years in the US and Europe where she was focused on understanding signal transduction pathways in neurology and oncology. She has since retrained as a Nuclear Medicine Technologist allowing her to bring her extensive research skills into the clinical Nuclear Medicine realm.
Alicia is currently employed at the Peter MacCallum Cancer Centre where she is the lead Nuclear Medicine Technologist responsible for research conducted on the Total Body PET. Alicia has experience coordinating with clinical trials teams and other imaging societies such as ARTnet and SNMMI to qualify and maintain imaging equipment for research. She has also developed imaging protocols and been involved in numerous molecular imaging and radionuclide therapy clinical trials. Her passion is to expand the use of molecular biology to identify new biomarkers that can be exploited to create new radiopharmaceuticals to advance theranostics in oncology.
NIF is pleased to announce that planning is underway for this year’s Annual Scientific Meeting, Australia’s flagship event for advanced imaging research and innovation. Dates: 30 July 2026, with c
05 February 2026
NIF is delighted about the news of Melbourne-based respiratory imaging 4DMedical’s recent significant capital raise of $150 million, as a NIF collaborator since the company’s founding.
20 January 2026
Today Monash University and the National Imaging Facility launched the most advanced MRI scanner in Victoria, which provides vastly better resolution and faster scans for patients.The new Siemens Heal
04 December 2025
Australian media has recognised the significance of the recent launch of the GE HealthCare total body PET/CT instrument and two new research centres: ACRF Centre for Advanced Imaging-Guided Therapeuti
21 November 2025